Global Meropenem Powder Injection Supply, Demand and Key Producers, 2026-2032
The global Meropenem Powder Injection market size is expected to reach $ 2521 million by 2032, rising at a market growth of 4.1% CAGR during the forecast period (2026-2032).
Meropenem Powder Injection is a sterile powder formulation of a broad-spectrum carbapenem antibiotic, widely used for the treatment of severe pneumonia, sepsis, complicated intra-abdominal infections, central nervous system infections, and other serious hospital-acquired infections caused by resistant Gram-negative pathogens, and it remains a cornerstone therapy in ICUs and critical care settings. Its upstream supply chain includes pharmaceutical-grade beta-lactam cores and key side-chain intermediates, excipients for sterile injectables such as buffers and stabilizers, water for injection, sterile vials and closures, as well as GMP-compliant aseptic manufacturing and quality control equipment, all of which require stringent impurity control, sterility assurance, and batch consistency. Downstream customers mainly consist of general hospitals, tertiary hospitals, regional medical centers, and specialty hospitals, with demand driven through centralized hospital procurement and reimbursement systems. Based on ex-factory pricing, global nominal production capacity of meropenem powder injection in 2025 is estimated at approximately 380 million vials, with actual sales volume of around 318 million vials and an average global ex-factory price of about USD 5.8 per vial. Supported by technical barriers in sterile manufacturing but constrained by persistent hospital pricing pressure, manufacturers typically achieve gross margins in the range of 40%?55%, reflecting stable demand, intense competition, and scalable yet sustainable profitability.
From a market perspective, the hospital anti-infective segment for meropenem powder injection has reached a highly mature stage, characterized by the coexistence of original brands and multiple generic manufacturers. Owing to its well-established clinical pathways and broad coverage of severe infections, meropenem has secured a foundational position in hospital formularies across many regions. Competitive dynamics have gradually shifted from brand-driven advantages toward comprehensive capabilities in quality consistency, batch reliability, and long-term supply assurance, favoring manufacturers with robust aseptic production systems and extensive regulatory experience.
On the demand side, the increasing proportion of critically ill patients, wider use of invasive medical procedures, and the complexity of infections caused by resistant Gram-negative pathogens continue to support sustained demand. At the same time, antimicrobial stewardship programs emphasize stratified and rational use, positioning meropenem within clearly defined indications rather than encouraging indiscriminate expansion. While such policies limit excessive utilization, they also reinforce the drug's essential role in severe and complicated infection management.
Looking ahead, market evolution is expected to focus on structural optimization and operational efficiency. Hospitals are placing greater emphasis on supply reliability, regulatory compliance, and traceability, which may accelerate consolidation toward manufacturers with scalable production and strong quality systems. In parallel, optimized dosing strategies, extended infusion practices, and combination therapies are enhancing the clinical value of meropenem beyond its role as a standalone antibiotic, even as newer antimicrobial agents introduce partial substitution in selected settings.
Against this backdrop, both growth drivers and constraints shape the long-term outlook. Cost containment measures, centralized procurement, and antibiotic use restrictions continue to exert pressure on pricing and volumes. Meanwhile, the high technical and compliance thresholds associated with sterile manufacturing increase operational complexity and sensitivity to upstream supply fluctuations. For manufacturers, maintaining competitiveness in the meropenem powder injection market will depend on balancing regulatory compliance, cost discipline, and dependable supply within an increasingly controlled healthcare environment.
This report studies the global Meropenem Powder Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Meropenem Powder Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Meropenem Powder Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Meropenem Powder Injection total production and demand, 2021-2032, (K Units)
Global Meropenem Powder Injection total production value, 2021-2032, (USD Million)
Global Meropenem Powder Injection production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Meropenem Powder Injection consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Meropenem Powder Injection domestic production, consumption, key domestic manufacturers and share
Global Meropenem Powder Injection production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Meropenem Powder Injection production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Meropenem Powder Injection production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Meropenem Powder Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sumitomo Pharma, Pfizer, Fresenius, Emcure Pharmaceuticals, Aurobindo Pharma, Sun Pharmaceutical, Hikma Pharmaceuticals, CSPC Pharmaceutical Group, Shenzhen Haibin Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Meropenem Powder Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Meropenem Powder Injection Market, By Region:
1. How big is the global Meropenem Powder Injection market?
2. What is the demand of the global Meropenem Powder Injection market?
3. What is the year over year growth of the global Meropenem Powder Injection market?
4. What is the production and production value of the global Meropenem Powder Injection market?
5. Who are the key producers in the global Meropenem Powder Injection market?
6. What are the growth factors driving the market demand?
Meropenem Powder Injection is a sterile powder formulation of a broad-spectrum carbapenem antibiotic, widely used for the treatment of severe pneumonia, sepsis, complicated intra-abdominal infections, central nervous system infections, and other serious hospital-acquired infections caused by resistant Gram-negative pathogens, and it remains a cornerstone therapy in ICUs and critical care settings. Its upstream supply chain includes pharmaceutical-grade beta-lactam cores and key side-chain intermediates, excipients for sterile injectables such as buffers and stabilizers, water for injection, sterile vials and closures, as well as GMP-compliant aseptic manufacturing and quality control equipment, all of which require stringent impurity control, sterility assurance, and batch consistency. Downstream customers mainly consist of general hospitals, tertiary hospitals, regional medical centers, and specialty hospitals, with demand driven through centralized hospital procurement and reimbursement systems. Based on ex-factory pricing, global nominal production capacity of meropenem powder injection in 2025 is estimated at approximately 380 million vials, with actual sales volume of around 318 million vials and an average global ex-factory price of about USD 5.8 per vial. Supported by technical barriers in sterile manufacturing but constrained by persistent hospital pricing pressure, manufacturers typically achieve gross margins in the range of 40%?55%, reflecting stable demand, intense competition, and scalable yet sustainable profitability.
From a market perspective, the hospital anti-infective segment for meropenem powder injection has reached a highly mature stage, characterized by the coexistence of original brands and multiple generic manufacturers. Owing to its well-established clinical pathways and broad coverage of severe infections, meropenem has secured a foundational position in hospital formularies across many regions. Competitive dynamics have gradually shifted from brand-driven advantages toward comprehensive capabilities in quality consistency, batch reliability, and long-term supply assurance, favoring manufacturers with robust aseptic production systems and extensive regulatory experience.
On the demand side, the increasing proportion of critically ill patients, wider use of invasive medical procedures, and the complexity of infections caused by resistant Gram-negative pathogens continue to support sustained demand. At the same time, antimicrobial stewardship programs emphasize stratified and rational use, positioning meropenem within clearly defined indications rather than encouraging indiscriminate expansion. While such policies limit excessive utilization, they also reinforce the drug's essential role in severe and complicated infection management.
Looking ahead, market evolution is expected to focus on structural optimization and operational efficiency. Hospitals are placing greater emphasis on supply reliability, regulatory compliance, and traceability, which may accelerate consolidation toward manufacturers with scalable production and strong quality systems. In parallel, optimized dosing strategies, extended infusion practices, and combination therapies are enhancing the clinical value of meropenem beyond its role as a standalone antibiotic, even as newer antimicrobial agents introduce partial substitution in selected settings.
Against this backdrop, both growth drivers and constraints shape the long-term outlook. Cost containment measures, centralized procurement, and antibiotic use restrictions continue to exert pressure on pricing and volumes. Meanwhile, the high technical and compliance thresholds associated with sterile manufacturing increase operational complexity and sensitivity to upstream supply fluctuations. For manufacturers, maintaining competitiveness in the meropenem powder injection market will depend on balancing regulatory compliance, cost discipline, and dependable supply within an increasingly controlled healthcare environment.
This report studies the global Meropenem Powder Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Meropenem Powder Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Meropenem Powder Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Meropenem Powder Injection total production and demand, 2021-2032, (K Units)
Global Meropenem Powder Injection total production value, 2021-2032, (USD Million)
Global Meropenem Powder Injection production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Meropenem Powder Injection consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Meropenem Powder Injection domestic production, consumption, key domestic manufacturers and share
Global Meropenem Powder Injection production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Meropenem Powder Injection production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Meropenem Powder Injection production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Meropenem Powder Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sumitomo Pharma, Pfizer, Fresenius, Emcure Pharmaceuticals, Aurobindo Pharma, Sun Pharmaceutical, Hikma Pharmaceuticals, CSPC Pharmaceutical Group, Shenzhen Haibin Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Meropenem Powder Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Meropenem Powder Injection Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 0.25 g (Calculated as C??H??N?O?S)
- 0.5 g (Calculated as C??H??N?O?S)
- 1.0 g (Calculated as C??H??N?O?S)
- Severe Hospital-acquired Infections
- Drug-resistant Gram-negative Infections
- Others
- Online Sales
- Offline Sales
- Hospital
- Clinic
- Others
- Sumitomo Pharma
- Pfizer
- Fresenius
- Emcure Pharmaceuticals
- Aurobindo Pharma
- Sun Pharmaceutical
- Hikma Pharmaceuticals
- CSPC Pharmaceutical Group
- Shenzhen Haibin Pharmaceutical
1. How big is the global Meropenem Powder Injection market?
2. What is the demand of the global Meropenem Powder Injection market?
3. What is the year over year growth of the global Meropenem Powder Injection market?
4. What is the production and production value of the global Meropenem Powder Injection market?
5. Who are the key producers in the global Meropenem Powder Injection market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Meropenem Powder Injection Introduction
1.2 World Meropenem Powder Injection Supply & Forecast
1.2.1 World Meropenem Powder Injection Production Value (2021 & 2025 & 2032)
1.2.2 World Meropenem Powder Injection Production (2021-2032)
1.2.3 World Meropenem Powder Injection Pricing Trends (2021-2032)
1.3 World Meropenem Powder Injection Production by Region (Based on Production Site)
1.3.1 World Meropenem Powder Injection Production Value by Region (2021-2032)
1.3.2 World Meropenem Powder Injection Production by Region (2021-2032)
1.3.3 World Meropenem Powder Injection Average Price by Region (2021-2032)
1.3.4 North America Meropenem Powder Injection Production (2021-2032)
1.3.5 Europe Meropenem Powder Injection Production (2021-2032)
1.3.6 China Meropenem Powder Injection Production (2021-2032)
1.3.7 Japan Meropenem Powder Injection Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Meropenem Powder Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Meropenem Powder Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Meropenem Powder Injection Demand (2021-2032)
2.2 World Meropenem Powder Injection Consumption by Region
2.2.1 World Meropenem Powder Injection Consumption by Region (2021-2026)
2.2.2 World Meropenem Powder Injection Consumption Forecast by Region (2027-2032)
2.3 United States Meropenem Powder Injection Consumption (2021-2032)
2.4 China Meropenem Powder Injection Consumption (2021-2032)
2.5 Europe Meropenem Powder Injection Consumption (2021-2032)
2.6 Japan Meropenem Powder Injection Consumption (2021-2032)
2.7 South Korea Meropenem Powder Injection Consumption (2021-2032)
2.8 ASEAN Meropenem Powder Injection Consumption (2021-2032)
2.9 India Meropenem Powder Injection Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Meropenem Powder Injection Production Value by Manufacturer (2021-2026)
3.2 World Meropenem Powder Injection Production by Manufacturer (2021-2026)
3.3 World Meropenem Powder Injection Average Price by Manufacturer (2021-2026)
3.4 Meropenem Powder Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Meropenem Powder Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Meropenem Powder Injection in 2025
3.5.3 Global Concentration Ratios (CR8) for Meropenem Powder Injection in 2025
3.6 Meropenem Powder Injection Market: Overall Company Footprint Analysis
3.6.1 Meropenem Powder Injection Market: Region Footprint
3.6.2 Meropenem Powder Injection Market: Company Product Type Footprint
3.6.3 Meropenem Powder Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Meropenem Powder Injection Production Value Comparison
4.1.1 United States VS China: Meropenem Powder Injection Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Meropenem Powder Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Meropenem Powder Injection Production Comparison
4.2.1 United States VS China: Meropenem Powder Injection Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Meropenem Powder Injection Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Meropenem Powder Injection Consumption Comparison
4.3.1 United States VS China: Meropenem Powder Injection Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Meropenem Powder Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Meropenem Powder Injection Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Meropenem Powder Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Meropenem Powder Injection Production Value (2021-2026)
4.4.3 United States Based Manufacturers Meropenem Powder Injection Production (2021-2026)
4.5 China Based Meropenem Powder Injection Manufacturers and Market Share
4.5.1 China Based Meropenem Powder Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Meropenem Powder Injection Production Value (2021-2026)
4.5.3 China Based Manufacturers Meropenem Powder Injection Production (2021-2026)
4.6 Rest of World Based Meropenem Powder Injection Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Meropenem Powder Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Meropenem Powder Injection Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Meropenem Powder Injection Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Meropenem Powder Injection Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 0.25 g (Calculated as C??H??N?O?S)
5.2.2 0.5 g (Calculated as C??H??N?O?S)
5.2.3 1.0 g (Calculated as C??H??N?O?S)
5.3 Market Segment by Type
5.3.1 World Meropenem Powder Injection Production by Type (2021-2032)
5.3.2 World Meropenem Powder Injection Production Value by Type (2021-2032)
5.3.3 World Meropenem Powder Injection Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY CLINICAL INDICATION
6.1 World Meropenem Powder Injection Market Size Overview by Clinical Indication: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Clinical Indication
6.2.1 Severe Hospital-acquired Infections
6.2.2 Drug-resistant Gram-negative Infections
6.2.3 Others
6.3 Market Segment by Clinical Indication
6.3.1 World Meropenem Powder Injection Production by Clinical Indication (2021-2032)
6.3.2 World Meropenem Powder Injection Production Value by Clinical Indication (2021-2032)
6.3.3 World Meropenem Powder Injection Average Price by Clinical Indication (2021-2032)
7 MARKET ANALYSIS BY SALE CHANNELS
7.1 World Meropenem Powder Injection Market Size Overview by Sale Channels: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sale Channels
7.2.1 Online Sales
7.2.2 Offline Sales
7.3 Market Segment by Sale Channels
7.3.1 World Meropenem Powder Injection Production by Sale Channels (2021-2032)
7.3.2 World Meropenem Powder Injection Production Value by Sale Channels (2021-2032)
7.3.3 World Meropenem Powder Injection Average Price by Sale Channels (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Meropenem Powder Injection Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Meropenem Powder Injection Production by Application (2021-2032)
8.3.2 World Meropenem Powder Injection Production Value by Application (2021-2032)
8.3.3 World Meropenem Powder Injection Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Sumitomo Pharma
9.1.1 Sumitomo Pharma Details
9.1.2 Sumitomo Pharma Major Business
9.1.3 Sumitomo Pharma Meropenem Powder Injection Product and Services
9.1.4 Sumitomo Pharma Meropenem Powder Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Sumitomo Pharma Recent Developments/Updates
9.1.6 Sumitomo Pharma Competitive Strengths & Weaknesses
9.2 Pfizer
9.2.1 Pfizer Details
9.2.2 Pfizer Major Business
9.2.3 Pfizer Meropenem Powder Injection Product and Services
9.2.4 Pfizer Meropenem Powder Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Pfizer Recent Developments/Updates
9.2.6 Pfizer Competitive Strengths & Weaknesses
9.3 Fresenius
9.3.1 Fresenius Details
9.3.2 Fresenius Major Business
9.3.3 Fresenius Meropenem Powder Injection Product and Services
9.3.4 Fresenius Meropenem Powder Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Fresenius Recent Developments/Updates
9.3.6 Fresenius Competitive Strengths & Weaknesses
9.4 Emcure Pharmaceuticals
9.4.1 Emcure Pharmaceuticals Details
9.4.2 Emcure Pharmaceuticals Major Business
9.4.3 Emcure Pharmaceuticals Meropenem Powder Injection Product and Services
9.4.4 Emcure Pharmaceuticals Meropenem Powder Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Emcure Pharmaceuticals Recent Developments/Updates
9.4.6 Emcure Pharmaceuticals Competitive Strengths & Weaknesses
9.5 Aurobindo Pharma
9.5.1 Aurobindo Pharma Details
9.5.2 Aurobindo Pharma Major Business
9.5.3 Aurobindo Pharma Meropenem Powder Injection Product and Services
9.5.4 Aurobindo Pharma Meropenem Powder Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Aurobindo Pharma Recent Developments/Updates
9.5.6 Aurobindo Pharma Competitive Strengths & Weaknesses
9.6 Sun Pharmaceutical
9.6.1 Sun Pharmaceutical Details
9.6.2 Sun Pharmaceutical Major Business
9.6.3 Sun Pharmaceutical Meropenem Powder Injection Product and Services
9.6.4 Sun Pharmaceutical Meropenem Powder Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Sun Pharmaceutical Recent Developments/Updates
9.6.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
9.7 Hikma Pharmaceuticals
9.7.1 Hikma Pharmaceuticals Details
9.7.2 Hikma Pharmaceuticals Major Business
9.7.3 Hikma Pharmaceuticals Meropenem Powder Injection Product and Services
9.7.4 Hikma Pharmaceuticals Meropenem Powder Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Hikma Pharmaceuticals Recent Developments/Updates
9.7.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
9.8 CSPC Pharmaceutical Group
9.8.1 CSPC Pharmaceutical Group Details
9.8.2 CSPC Pharmaceutical Group Major Business
9.8.3 CSPC Pharmaceutical Group Meropenem Powder Injection Product and Services
9.8.4 CSPC Pharmaceutical Group Meropenem Powder Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 CSPC Pharmaceutical Group Recent Developments/Updates
9.8.6 CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
9.9 Shenzhen Haibin Pharmaceutical
9.9.1 Shenzhen Haibin Pharmaceutical Details
9.9.2 Shenzhen Haibin Pharmaceutical Major Business
9.9.3 Shenzhen Haibin Pharmaceutical Meropenem Powder Injection Product and Services
9.9.4 Shenzhen Haibin Pharmaceutical Meropenem Powder Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
9.9.6 Shenzhen Haibin Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Meropenem Powder Injection Industry Chain
10.2 Meropenem Powder Injection Upstream Analysis
10.2.1 Meropenem Powder Injection Core Raw Materials
10.2.2 Main Manufacturers of Meropenem Powder Injection Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Meropenem Powder Injection Production Mode
10.6 Meropenem Powder Injection Procurement Model
10.7 Meropenem Powder Injection Industry Sales Model and Sales Channels
10.7.1 Meropenem Powder Injection Sales Model
10.7.2 Meropenem Powder Injection Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Meropenem Powder Injection Introduction
1.2 World Meropenem Powder Injection Supply & Forecast
1.2.1 World Meropenem Powder Injection Production Value (2021 & 2025 & 2032)
1.2.2 World Meropenem Powder Injection Production (2021-2032)
1.2.3 World Meropenem Powder Injection Pricing Trends (2021-2032)
1.3 World Meropenem Powder Injection Production by Region (Based on Production Site)
1.3.1 World Meropenem Powder Injection Production Value by Region (2021-2032)
1.3.2 World Meropenem Powder Injection Production by Region (2021-2032)
1.3.3 World Meropenem Powder Injection Average Price by Region (2021-2032)
1.3.4 North America Meropenem Powder Injection Production (2021-2032)
1.3.5 Europe Meropenem Powder Injection Production (2021-2032)
1.3.6 China Meropenem Powder Injection Production (2021-2032)
1.3.7 Japan Meropenem Powder Injection Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Meropenem Powder Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Meropenem Powder Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Meropenem Powder Injection Demand (2021-2032)
2.2 World Meropenem Powder Injection Consumption by Region
2.2.1 World Meropenem Powder Injection Consumption by Region (2021-2026)
2.2.2 World Meropenem Powder Injection Consumption Forecast by Region (2027-2032)
2.3 United States Meropenem Powder Injection Consumption (2021-2032)
2.4 China Meropenem Powder Injection Consumption (2021-2032)
2.5 Europe Meropenem Powder Injection Consumption (2021-2032)
2.6 Japan Meropenem Powder Injection Consumption (2021-2032)
2.7 South Korea Meropenem Powder Injection Consumption (2021-2032)
2.8 ASEAN Meropenem Powder Injection Consumption (2021-2032)
2.9 India Meropenem Powder Injection Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Meropenem Powder Injection Production Value by Manufacturer (2021-2026)
3.2 World Meropenem Powder Injection Production by Manufacturer (2021-2026)
3.3 World Meropenem Powder Injection Average Price by Manufacturer (2021-2026)
3.4 Meropenem Powder Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Meropenem Powder Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Meropenem Powder Injection in 2025
3.5.3 Global Concentration Ratios (CR8) for Meropenem Powder Injection in 2025
3.6 Meropenem Powder Injection Market: Overall Company Footprint Analysis
3.6.1 Meropenem Powder Injection Market: Region Footprint
3.6.2 Meropenem Powder Injection Market: Company Product Type Footprint
3.6.3 Meropenem Powder Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Meropenem Powder Injection Production Value Comparison
4.1.1 United States VS China: Meropenem Powder Injection Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Meropenem Powder Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Meropenem Powder Injection Production Comparison
4.2.1 United States VS China: Meropenem Powder Injection Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Meropenem Powder Injection Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Meropenem Powder Injection Consumption Comparison
4.3.1 United States VS China: Meropenem Powder Injection Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Meropenem Powder Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Meropenem Powder Injection Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Meropenem Powder Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Meropenem Powder Injection Production Value (2021-2026)
4.4.3 United States Based Manufacturers Meropenem Powder Injection Production (2021-2026)
4.5 China Based Meropenem Powder Injection Manufacturers and Market Share
4.5.1 China Based Meropenem Powder Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Meropenem Powder Injection Production Value (2021-2026)
4.5.3 China Based Manufacturers Meropenem Powder Injection Production (2021-2026)
4.6 Rest of World Based Meropenem Powder Injection Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Meropenem Powder Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Meropenem Powder Injection Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Meropenem Powder Injection Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Meropenem Powder Injection Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 0.25 g (Calculated as C??H??N?O?S)
5.2.2 0.5 g (Calculated as C??H??N?O?S)
5.2.3 1.0 g (Calculated as C??H??N?O?S)
5.3 Market Segment by Type
5.3.1 World Meropenem Powder Injection Production by Type (2021-2032)
5.3.2 World Meropenem Powder Injection Production Value by Type (2021-2032)
5.3.3 World Meropenem Powder Injection Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY CLINICAL INDICATION
6.1 World Meropenem Powder Injection Market Size Overview by Clinical Indication: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Clinical Indication
6.2.1 Severe Hospital-acquired Infections
6.2.2 Drug-resistant Gram-negative Infections
6.2.3 Others
6.3 Market Segment by Clinical Indication
6.3.1 World Meropenem Powder Injection Production by Clinical Indication (2021-2032)
6.3.2 World Meropenem Powder Injection Production Value by Clinical Indication (2021-2032)
6.3.3 World Meropenem Powder Injection Average Price by Clinical Indication (2021-2032)
7 MARKET ANALYSIS BY SALE CHANNELS
7.1 World Meropenem Powder Injection Market Size Overview by Sale Channels: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sale Channels
7.2.1 Online Sales
7.2.2 Offline Sales
7.3 Market Segment by Sale Channels
7.3.1 World Meropenem Powder Injection Production by Sale Channels (2021-2032)
7.3.2 World Meropenem Powder Injection Production Value by Sale Channels (2021-2032)
7.3.3 World Meropenem Powder Injection Average Price by Sale Channels (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Meropenem Powder Injection Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Meropenem Powder Injection Production by Application (2021-2032)
8.3.2 World Meropenem Powder Injection Production Value by Application (2021-2032)
8.3.3 World Meropenem Powder Injection Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Sumitomo Pharma
9.1.1 Sumitomo Pharma Details
9.1.2 Sumitomo Pharma Major Business
9.1.3 Sumitomo Pharma Meropenem Powder Injection Product and Services
9.1.4 Sumitomo Pharma Meropenem Powder Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Sumitomo Pharma Recent Developments/Updates
9.1.6 Sumitomo Pharma Competitive Strengths & Weaknesses
9.2 Pfizer
9.2.1 Pfizer Details
9.2.2 Pfizer Major Business
9.2.3 Pfizer Meropenem Powder Injection Product and Services
9.2.4 Pfizer Meropenem Powder Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Pfizer Recent Developments/Updates
9.2.6 Pfizer Competitive Strengths & Weaknesses
9.3 Fresenius
9.3.1 Fresenius Details
9.3.2 Fresenius Major Business
9.3.3 Fresenius Meropenem Powder Injection Product and Services
9.3.4 Fresenius Meropenem Powder Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Fresenius Recent Developments/Updates
9.3.6 Fresenius Competitive Strengths & Weaknesses
9.4 Emcure Pharmaceuticals
9.4.1 Emcure Pharmaceuticals Details
9.4.2 Emcure Pharmaceuticals Major Business
9.4.3 Emcure Pharmaceuticals Meropenem Powder Injection Product and Services
9.4.4 Emcure Pharmaceuticals Meropenem Powder Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Emcure Pharmaceuticals Recent Developments/Updates
9.4.6 Emcure Pharmaceuticals Competitive Strengths & Weaknesses
9.5 Aurobindo Pharma
9.5.1 Aurobindo Pharma Details
9.5.2 Aurobindo Pharma Major Business
9.5.3 Aurobindo Pharma Meropenem Powder Injection Product and Services
9.5.4 Aurobindo Pharma Meropenem Powder Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Aurobindo Pharma Recent Developments/Updates
9.5.6 Aurobindo Pharma Competitive Strengths & Weaknesses
9.6 Sun Pharmaceutical
9.6.1 Sun Pharmaceutical Details
9.6.2 Sun Pharmaceutical Major Business
9.6.3 Sun Pharmaceutical Meropenem Powder Injection Product and Services
9.6.4 Sun Pharmaceutical Meropenem Powder Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Sun Pharmaceutical Recent Developments/Updates
9.6.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
9.7 Hikma Pharmaceuticals
9.7.1 Hikma Pharmaceuticals Details
9.7.2 Hikma Pharmaceuticals Major Business
9.7.3 Hikma Pharmaceuticals Meropenem Powder Injection Product and Services
9.7.4 Hikma Pharmaceuticals Meropenem Powder Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Hikma Pharmaceuticals Recent Developments/Updates
9.7.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
9.8 CSPC Pharmaceutical Group
9.8.1 CSPC Pharmaceutical Group Details
9.8.2 CSPC Pharmaceutical Group Major Business
9.8.3 CSPC Pharmaceutical Group Meropenem Powder Injection Product and Services
9.8.4 CSPC Pharmaceutical Group Meropenem Powder Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 CSPC Pharmaceutical Group Recent Developments/Updates
9.8.6 CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
9.9 Shenzhen Haibin Pharmaceutical
9.9.1 Shenzhen Haibin Pharmaceutical Details
9.9.2 Shenzhen Haibin Pharmaceutical Major Business
9.9.3 Shenzhen Haibin Pharmaceutical Meropenem Powder Injection Product and Services
9.9.4 Shenzhen Haibin Pharmaceutical Meropenem Powder Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
9.9.6 Shenzhen Haibin Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Meropenem Powder Injection Industry Chain
10.2 Meropenem Powder Injection Upstream Analysis
10.2.1 Meropenem Powder Injection Core Raw Materials
10.2.2 Main Manufacturers of Meropenem Powder Injection Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Meropenem Powder Injection Production Mode
10.6 Meropenem Powder Injection Procurement Model
10.7 Meropenem Powder Injection Industry Sales Model and Sales Channels
10.7.1 Meropenem Powder Injection Sales Model
10.7.2 Meropenem Powder Injection Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Meropenem Powder Injection Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Meropenem Powder Injection Production Value by Region (2021-2026) & (USD Million)
Table 3. World Meropenem Powder Injection Production Value by Region (2027-2032) & (USD Million)
Table 4. World Meropenem Powder Injection Production Value Market Share by Region (2021-2026)
Table 5. World Meropenem Powder Injection Production Value Market Share by Region (2027-2032)
Table 6. World Meropenem Powder Injection Production by Region (2021-2026) & (K Units)
Table 7. World Meropenem Powder Injection Production by Region (2027-2032) & (K Units)
Table 8. World Meropenem Powder Injection Production Market Share by Region (2021-2026)
Table 9. World Meropenem Powder Injection Production Market Share by Region (2027-2032)
Table 10. World Meropenem Powder Injection Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Meropenem Powder Injection Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Meropenem Powder Injection Major Market Trends
Table 13. World Meropenem Powder Injection Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Meropenem Powder Injection Consumption by Region (2021-2026) & (K Units)
Table 15. World Meropenem Powder Injection Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Meropenem Powder Injection Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Meropenem Powder Injection Producers in 2025
Table 18. World Meropenem Powder Injection Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Meropenem Powder Injection Producers in 2025
Table 20. World Meropenem Powder Injection Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Meropenem Powder Injection Company Evaluation Quadrant
Table 22. World Meropenem Powder Injection Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Meropenem Powder Injection Production Site of Key Manufacturer
Table 24. Meropenem Powder Injection Market: Company Product Type Footprint
Table 25. Meropenem Powder Injection Market: Company Product Application Footprint
Table 26. Meropenem Powder Injection Competitive Factors
Table 27. Meropenem Powder Injection New Entrant and Capacity Expansion Plans
Table 28. Meropenem Powder Injection Mergers & Acquisitions Activity
Table 29. United States VS China Meropenem Powder Injection Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Meropenem Powder Injection Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Meropenem Powder Injection Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Meropenem Powder Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Meropenem Powder Injection Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Meropenem Powder Injection Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Meropenem Powder Injection Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Meropenem Powder Injection Production Market Share (2021-2026)
Table 37. China Based Meropenem Powder Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Meropenem Powder Injection Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Meropenem Powder Injection Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Meropenem Powder Injection Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Meropenem Powder Injection Production Market Share (2021-2026)
Table 42. Rest of World Based Meropenem Powder Injection Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Meropenem Powder Injection Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Meropenem Powder Injection Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Meropenem Powder Injection Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Meropenem Powder Injection Production Market Share (2021-2026)
Table 47. World Meropenem Powder Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Meropenem Powder Injection Production by Type (2021-2026) & (K Units)
Table 49. World Meropenem Powder Injection Production by Type (2027-2032) & (K Units)
Table 50. World Meropenem Powder Injection Production Value by Type (2021-2026) & (USD Million)
Table 51. World Meropenem Powder Injection Production Value by Type (2027-2032) & (USD Million)
Table 52. World Meropenem Powder Injection Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Meropenem Powder Injection Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Meropenem Powder Injection Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Table 55. World Meropenem Powder Injection Production by Clinical Indication (2021-2026) & (K Units)
Table 56. World Meropenem Powder Injection Production by Clinical Indication (2027-2032) & (K Units)
Table 57. World Meropenem Powder Injection Production Value by Clinical Indication (2021-2026) & (USD Million)
Table 58. World Meropenem Powder Injection Production Value by Clinical Indication (2027-2032) & (USD Million)
Table 59. World Meropenem Powder Injection Average Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 60. World Meropenem Powder Injection Average Price by Clinical Indication (2027-2032) & (US$/Unit)
Table 61. World Meropenem Powder Injection Production Value by Sale Channels, (USD Million), 2021 & 2025 & 2032
Table 62. World Meropenem Powder Injection Production by Sale Channels (2021-2026) & (K Units)
Table 63. World Meropenem Powder Injection Production by Sale Channels (2027-2032) & (K Units)
Table 64. World Meropenem Powder Injection Production Value by Sale Channels (2021-2026) & (USD Million)
Table 65. World Meropenem Powder Injection Production Value by Sale Channels (2027-2032) & (USD Million)
Table 66. World Meropenem Powder Injection Average Price by Sale Channels (2021-2026) & (US$/Unit)
Table 67. World Meropenem Powder Injection Average Price by Sale Channels (2027-2032) & (US$/Unit)
Table 68. World Meropenem Powder Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Meropenem Powder Injection Production by Application (2021-2026) & (K Units)
Table 70. World Meropenem Powder Injection Production by Application (2027-2032) & (K Units)
Table 71. World Meropenem Powder Injection Production Value by Application (2021-2026) & (USD Million)
Table 72. World Meropenem Powder Injection Production Value by Application (2027-2032) & (USD Million)
Table 73. World Meropenem Powder Injection Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Meropenem Powder Injection Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 76. Sumitomo Pharma Major Business
Table 77. Sumitomo Pharma Meropenem Powder Injection Product and Services
Table 78. Sumitomo Pharma Meropenem Powder Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Sumitomo Pharma Recent Developments/Updates
Table 80. Sumitomo Pharma Competitive Strengths & Weaknesses
Table 81. Pfizer Basic Information, Manufacturing Base and Competitors
Table 82. Pfizer Major Business
Table 83. Pfizer Meropenem Powder Injection Product and Services
Table 84. Pfizer Meropenem Powder Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Pfizer Recent Developments/Updates
Table 86. Pfizer Competitive Strengths & Weaknesses
Table 87. Fresenius Basic Information, Manufacturing Base and Competitors
Table 88. Fresenius Major Business
Table 89. Fresenius Meropenem Powder Injection Product and Services
Table 90. Fresenius Meropenem Powder Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Fresenius Recent Developments/Updates
Table 92. Fresenius Competitive Strengths & Weaknesses
Table 93. Emcure Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 94. Emcure Pharmaceuticals Major Business
Table 95. Emcure Pharmaceuticals Meropenem Powder Injection Product and Services
Table 96. Emcure Pharmaceuticals Meropenem Powder Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Emcure Pharmaceuticals Recent Developments/Updates
Table 98. Emcure Pharmaceuticals Competitive Strengths & Weaknesses
Table 99. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 100. Aurobindo Pharma Major Business
Table 101. Aurobindo Pharma Meropenem Powder Injection Product and Services
Table 102. Aurobindo Pharma Meropenem Powder Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Aurobindo Pharma Recent Developments/Updates
Table 104. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 105. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 106. Sun Pharmaceutical Major Business
Table 107. Sun Pharmaceutical Meropenem Powder Injection Product and Services
Table 108. Sun Pharmaceutical Meropenem Powder Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Sun Pharmaceutical Recent Developments/Updates
Table 110. Sun Pharmaceutical Competitive Strengths & Weaknesses
Table 111. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 112. Hikma Pharmaceuticals Major Business
Table 113. Hikma Pharmaceuticals Meropenem Powder Injection Product and Services
Table 114. Hikma Pharmaceuticals Meropenem Powder Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Hikma Pharmaceuticals Recent Developments/Updates
Table 116. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 117. CSPC Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 118. CSPC Pharmaceutical Group Major Business
Table 119. CSPC Pharmaceutical Group Meropenem Powder Injection Product and Services
Table 120. CSPC Pharmaceutical Group Meropenem Powder Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. CSPC Pharmaceutical Group Recent Developments/Updates
Table 122. CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
Table 123. Shenzhen Haibin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 124. Shenzhen Haibin Pharmaceutical Major Business
Table 125. Shenzhen Haibin Pharmaceutical Meropenem Powder Injection Product and Services
Table 126. Shenzhen Haibin Pharmaceutical Meropenem Powder Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 128. Shenzhen Haibin Pharmaceutical Competitive Strengths & Weaknesses
Table 129. Global Key Players of Meropenem Powder Injection Upstream (Raw Materials)
Table 130. Global Meropenem Powder Injection Typical Customers
Table 131. Meropenem Powder Injection Typical Distributors
Table 1. World Meropenem Powder Injection Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Meropenem Powder Injection Production Value by Region (2021-2026) & (USD Million)
Table 3. World Meropenem Powder Injection Production Value by Region (2027-2032) & (USD Million)
Table 4. World Meropenem Powder Injection Production Value Market Share by Region (2021-2026)
Table 5. World Meropenem Powder Injection Production Value Market Share by Region (2027-2032)
Table 6. World Meropenem Powder Injection Production by Region (2021-2026) & (K Units)
Table 7. World Meropenem Powder Injection Production by Region (2027-2032) & (K Units)
Table 8. World Meropenem Powder Injection Production Market Share by Region (2021-2026)
Table 9. World Meropenem Powder Injection Production Market Share by Region (2027-2032)
Table 10. World Meropenem Powder Injection Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Meropenem Powder Injection Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Meropenem Powder Injection Major Market Trends
Table 13. World Meropenem Powder Injection Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Meropenem Powder Injection Consumption by Region (2021-2026) & (K Units)
Table 15. World Meropenem Powder Injection Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Meropenem Powder Injection Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Meropenem Powder Injection Producers in 2025
Table 18. World Meropenem Powder Injection Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Meropenem Powder Injection Producers in 2025
Table 20. World Meropenem Powder Injection Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Meropenem Powder Injection Company Evaluation Quadrant
Table 22. World Meropenem Powder Injection Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Meropenem Powder Injection Production Site of Key Manufacturer
Table 24. Meropenem Powder Injection Market: Company Product Type Footprint
Table 25. Meropenem Powder Injection Market: Company Product Application Footprint
Table 26. Meropenem Powder Injection Competitive Factors
Table 27. Meropenem Powder Injection New Entrant and Capacity Expansion Plans
Table 28. Meropenem Powder Injection Mergers & Acquisitions Activity
Table 29. United States VS China Meropenem Powder Injection Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Meropenem Powder Injection Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Meropenem Powder Injection Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Meropenem Powder Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Meropenem Powder Injection Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Meropenem Powder Injection Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Meropenem Powder Injection Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Meropenem Powder Injection Production Market Share (2021-2026)
Table 37. China Based Meropenem Powder Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Meropenem Powder Injection Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Meropenem Powder Injection Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Meropenem Powder Injection Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Meropenem Powder Injection Production Market Share (2021-2026)
Table 42. Rest of World Based Meropenem Powder Injection Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Meropenem Powder Injection Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Meropenem Powder Injection Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Meropenem Powder Injection Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Meropenem Powder Injection Production Market Share (2021-2026)
Table 47. World Meropenem Powder Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Meropenem Powder Injection Production by Type (2021-2026) & (K Units)
Table 49. World Meropenem Powder Injection Production by Type (2027-2032) & (K Units)
Table 50. World Meropenem Powder Injection Production Value by Type (2021-2026) & (USD Million)
Table 51. World Meropenem Powder Injection Production Value by Type (2027-2032) & (USD Million)
Table 52. World Meropenem Powder Injection Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Meropenem Powder Injection Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Meropenem Powder Injection Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Table 55. World Meropenem Powder Injection Production by Clinical Indication (2021-2026) & (K Units)
Table 56. World Meropenem Powder Injection Production by Clinical Indication (2027-2032) & (K Units)
Table 57. World Meropenem Powder Injection Production Value by Clinical Indication (2021-2026) & (USD Million)
Table 58. World Meropenem Powder Injection Production Value by Clinical Indication (2027-2032) & (USD Million)
Table 59. World Meropenem Powder Injection Average Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 60. World Meropenem Powder Injection Average Price by Clinical Indication (2027-2032) & (US$/Unit)
Table 61. World Meropenem Powder Injection Production Value by Sale Channels, (USD Million), 2021 & 2025 & 2032
Table 62. World Meropenem Powder Injection Production by Sale Channels (2021-2026) & (K Units)
Table 63. World Meropenem Powder Injection Production by Sale Channels (2027-2032) & (K Units)
Table 64. World Meropenem Powder Injection Production Value by Sale Channels (2021-2026) & (USD Million)
Table 65. World Meropenem Powder Injection Production Value by Sale Channels (2027-2032) & (USD Million)
Table 66. World Meropenem Powder Injection Average Price by Sale Channels (2021-2026) & (US$/Unit)
Table 67. World Meropenem Powder Injection Average Price by Sale Channels (2027-2032) & (US$/Unit)
Table 68. World Meropenem Powder Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Meropenem Powder Injection Production by Application (2021-2026) & (K Units)
Table 70. World Meropenem Powder Injection Production by Application (2027-2032) & (K Units)
Table 71. World Meropenem Powder Injection Production Value by Application (2021-2026) & (USD Million)
Table 72. World Meropenem Powder Injection Production Value by Application (2027-2032) & (USD Million)
Table 73. World Meropenem Powder Injection Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Meropenem Powder Injection Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 76. Sumitomo Pharma Major Business
Table 77. Sumitomo Pharma Meropenem Powder Injection Product and Services
Table 78. Sumitomo Pharma Meropenem Powder Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Sumitomo Pharma Recent Developments/Updates
Table 80. Sumitomo Pharma Competitive Strengths & Weaknesses
Table 81. Pfizer Basic Information, Manufacturing Base and Competitors
Table 82. Pfizer Major Business
Table 83. Pfizer Meropenem Powder Injection Product and Services
Table 84. Pfizer Meropenem Powder Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Pfizer Recent Developments/Updates
Table 86. Pfizer Competitive Strengths & Weaknesses
Table 87. Fresenius Basic Information, Manufacturing Base and Competitors
Table 88. Fresenius Major Business
Table 89. Fresenius Meropenem Powder Injection Product and Services
Table 90. Fresenius Meropenem Powder Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Fresenius Recent Developments/Updates
Table 92. Fresenius Competitive Strengths & Weaknesses
Table 93. Emcure Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 94. Emcure Pharmaceuticals Major Business
Table 95. Emcure Pharmaceuticals Meropenem Powder Injection Product and Services
Table 96. Emcure Pharmaceuticals Meropenem Powder Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Emcure Pharmaceuticals Recent Developments/Updates
Table 98. Emcure Pharmaceuticals Competitive Strengths & Weaknesses
Table 99. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 100. Aurobindo Pharma Major Business
Table 101. Aurobindo Pharma Meropenem Powder Injection Product and Services
Table 102. Aurobindo Pharma Meropenem Powder Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Aurobindo Pharma Recent Developments/Updates
Table 104. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 105. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 106. Sun Pharmaceutical Major Business
Table 107. Sun Pharmaceutical Meropenem Powder Injection Product and Services
Table 108. Sun Pharmaceutical Meropenem Powder Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Sun Pharmaceutical Recent Developments/Updates
Table 110. Sun Pharmaceutical Competitive Strengths & Weaknesses
Table 111. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 112. Hikma Pharmaceuticals Major Business
Table 113. Hikma Pharmaceuticals Meropenem Powder Injection Product and Services
Table 114. Hikma Pharmaceuticals Meropenem Powder Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Hikma Pharmaceuticals Recent Developments/Updates
Table 116. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 117. CSPC Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 118. CSPC Pharmaceutical Group Major Business
Table 119. CSPC Pharmaceutical Group Meropenem Powder Injection Product and Services
Table 120. CSPC Pharmaceutical Group Meropenem Powder Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. CSPC Pharmaceutical Group Recent Developments/Updates
Table 122. CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
Table 123. Shenzhen Haibin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 124. Shenzhen Haibin Pharmaceutical Major Business
Table 125. Shenzhen Haibin Pharmaceutical Meropenem Powder Injection Product and Services
Table 126. Shenzhen Haibin Pharmaceutical Meropenem Powder Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 128. Shenzhen Haibin Pharmaceutical Competitive Strengths & Weaknesses
Table 129. Global Key Players of Meropenem Powder Injection Upstream (Raw Materials)
Table 130. Global Meropenem Powder Injection Typical Customers
Table 131. Meropenem Powder Injection Typical Distributors
LIST OF FIGURES
Figure 1. Meropenem Powder Injection Picture
Figure 2. World Meropenem Powder Injection Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Meropenem Powder Injection Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Meropenem Powder Injection Production (2021-2032) & (K Units)
Figure 5. World Meropenem Powder Injection Average Price (2021-2032) & (US$/Unit)
Figure 6. World Meropenem Powder Injection Production Value Market Share by Region (2021-2032)
Figure 7. World Meropenem Powder Injection Production Market Share by Region (2021-2032)
Figure 8. North America Meropenem Powder Injection Production (2021-2032) & (K Units)
Figure 9. Europe Meropenem Powder Injection Production (2021-2032) & (K Units)
Figure 10. China Meropenem Powder Injection Production (2021-2032) & (K Units)
Figure 11. Japan Meropenem Powder Injection Production (2021-2032) & (K Units)
Figure 12. Meropenem Powder Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Meropenem Powder Injection Consumption (2021-2032) & (K Units)
Figure 15. World Meropenem Powder Injection Consumption Market Share by Region (2021-2032)
Figure 16. United States Meropenem Powder Injection Consumption (2021-2032) & (K Units)
Figure 17. China Meropenem Powder Injection Consumption (2021-2032) & (K Units)
Figure 18. Europe Meropenem Powder Injection Consumption (2021-2032) & (K Units)
Figure 19. Japan Meropenem Powder Injection Consumption (2021-2032) & (K Units)
Figure 20. South Korea Meropenem Powder Injection Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Meropenem Powder Injection Consumption (2021-2032) & (K Units)
Figure 22. India Meropenem Powder Injection Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Meropenem Powder Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Meropenem Powder Injection Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Meropenem Powder Injection Markets in 2025
Figure 26. United States VS China: Meropenem Powder Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Meropenem Powder Injection Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Meropenem Powder Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Meropenem Powder Injection Production Market Share 2025
Figure 30. China Based Manufacturers Meropenem Powder Injection Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Meropenem Powder Injection Production Market Share 2025
Figure 32. World Meropenem Powder Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Meropenem Powder Injection Production Value Market Share by Type in 2025
Figure 34. 0.25 g (Calculated as C??H??N?O?S)
Figure 35. 0.5 g (Calculated as C??H??N?O?S)
Figure 36. 1.0 g (Calculated as C??H??N?O?S)
Figure 37. World Meropenem Powder Injection Production Market Share by Type (2021-2032)
Figure 38. World Meropenem Powder Injection Production Value Market Share by Type (2021-2032)
Figure 39. World Meropenem Powder Injection Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Meropenem Powder Injection Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Figure 41. World Meropenem Powder Injection Production Value Market Share by Clinical Indication in 2025
Figure 42. Severe Hospital-acquired Infections
Figure 43. Drug-resistant Gram-negative Infections
Figure 44. Others
Figure 45. World Meropenem Powder Injection Production Market Share by Clinical Indication (2021-2032)
Figure 46. World Meropenem Powder Injection Production Value Market Share by Clinical Indication (2021-2032)
Figure 47. World Meropenem Powder Injection Average Price by Clinical Indication (2021-2032) & (US$/Unit)
Figure 48. World Meropenem Powder Injection Production Value by Sale Channels, (USD Million), 2021 & 2025 & 2032
Figure 49. World Meropenem Powder Injection Production Value Market Share by Sale Channels in 2025
Figure 50. Online Sales
Figure 51. Offline Sales
Figure 52. World Meropenem Powder Injection Production Market Share by Sale Channels (2021-2032)
Figure 53. World Meropenem Powder Injection Production Value Market Share by Sale Channels (2021-2032)
Figure 54. World Meropenem Powder Injection Average Price by Sale Channels (2021-2032) & (US$/Unit)
Figure 55. World Meropenem Powder Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Meropenem Powder Injection Production Value Market Share by Application in 2025
Figure 57. Hospital
Figure 58. Clinic
Figure 59. Others
Figure 60. World Meropenem Powder Injection Production Market Share by Application (2021-2032)
Figure 61. World Meropenem Powder Injection Production Value Market Share by Application (2021-2032)
Figure 62. World Meropenem Powder Injection Average Price by Application (2021-2032) & (US$/Unit)
Figure 63. Meropenem Powder Injection Industry Chain
Figure 64. Meropenem Powder Injection Procurement Model
Figure 65. Meropenem Powder Injection Sales Model
Figure 66. Meropenem Powder Injection Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
Figure 1. Meropenem Powder Injection Picture
Figure 2. World Meropenem Powder Injection Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Meropenem Powder Injection Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Meropenem Powder Injection Production (2021-2032) & (K Units)
Figure 5. World Meropenem Powder Injection Average Price (2021-2032) & (US$/Unit)
Figure 6. World Meropenem Powder Injection Production Value Market Share by Region (2021-2032)
Figure 7. World Meropenem Powder Injection Production Market Share by Region (2021-2032)
Figure 8. North America Meropenem Powder Injection Production (2021-2032) & (K Units)
Figure 9. Europe Meropenem Powder Injection Production (2021-2032) & (K Units)
Figure 10. China Meropenem Powder Injection Production (2021-2032) & (K Units)
Figure 11. Japan Meropenem Powder Injection Production (2021-2032) & (K Units)
Figure 12. Meropenem Powder Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Meropenem Powder Injection Consumption (2021-2032) & (K Units)
Figure 15. World Meropenem Powder Injection Consumption Market Share by Region (2021-2032)
Figure 16. United States Meropenem Powder Injection Consumption (2021-2032) & (K Units)
Figure 17. China Meropenem Powder Injection Consumption (2021-2032) & (K Units)
Figure 18. Europe Meropenem Powder Injection Consumption (2021-2032) & (K Units)
Figure 19. Japan Meropenem Powder Injection Consumption (2021-2032) & (K Units)
Figure 20. South Korea Meropenem Powder Injection Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Meropenem Powder Injection Consumption (2021-2032) & (K Units)
Figure 22. India Meropenem Powder Injection Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Meropenem Powder Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Meropenem Powder Injection Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Meropenem Powder Injection Markets in 2025
Figure 26. United States VS China: Meropenem Powder Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Meropenem Powder Injection Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Meropenem Powder Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Meropenem Powder Injection Production Market Share 2025
Figure 30. China Based Manufacturers Meropenem Powder Injection Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Meropenem Powder Injection Production Market Share 2025
Figure 32. World Meropenem Powder Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Meropenem Powder Injection Production Value Market Share by Type in 2025
Figure 34. 0.25 g (Calculated as C??H??N?O?S)
Figure 35. 0.5 g (Calculated as C??H??N?O?S)
Figure 36. 1.0 g (Calculated as C??H??N?O?S)
Figure 37. World Meropenem Powder Injection Production Market Share by Type (2021-2032)
Figure 38. World Meropenem Powder Injection Production Value Market Share by Type (2021-2032)
Figure 39. World Meropenem Powder Injection Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Meropenem Powder Injection Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Figure 41. World Meropenem Powder Injection Production Value Market Share by Clinical Indication in 2025
Figure 42. Severe Hospital-acquired Infections
Figure 43. Drug-resistant Gram-negative Infections
Figure 44. Others
Figure 45. World Meropenem Powder Injection Production Market Share by Clinical Indication (2021-2032)
Figure 46. World Meropenem Powder Injection Production Value Market Share by Clinical Indication (2021-2032)
Figure 47. World Meropenem Powder Injection Average Price by Clinical Indication (2021-2032) & (US$/Unit)
Figure 48. World Meropenem Powder Injection Production Value by Sale Channels, (USD Million), 2021 & 2025 & 2032
Figure 49. World Meropenem Powder Injection Production Value Market Share by Sale Channels in 2025
Figure 50. Online Sales
Figure 51. Offline Sales
Figure 52. World Meropenem Powder Injection Production Market Share by Sale Channels (2021-2032)
Figure 53. World Meropenem Powder Injection Production Value Market Share by Sale Channels (2021-2032)
Figure 54. World Meropenem Powder Injection Average Price by Sale Channels (2021-2032) & (US$/Unit)
Figure 55. World Meropenem Powder Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Meropenem Powder Injection Production Value Market Share by Application in 2025
Figure 57. Hospital
Figure 58. Clinic
Figure 59. Others
Figure 60. World Meropenem Powder Injection Production Market Share by Application (2021-2032)
Figure 61. World Meropenem Powder Injection Production Value Market Share by Application (2021-2032)
Figure 62. World Meropenem Powder Injection Average Price by Application (2021-2032) & (US$/Unit)
Figure 63. Meropenem Powder Injection Industry Chain
Figure 64. Meropenem Powder Injection Procurement Model
Figure 65. Meropenem Powder Injection Sales Model
Figure 66. Meropenem Powder Injection Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
